Skip to main content

Table 2 Demographic data, indication for cfLVAD-implantation and medical history of patients included in the derivation and the validation cohort. Values are expressed as numbers and % of patients, mean ± SD, or median [Interquartile Range]

From: Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors

 

Derivation cohort

118 patients

Validation cohort

72 patients

Demographic data

 Age (years)

49.4 ± 12.8

51.2 ± 13.0

 Male gender

83 (70.3%)

49 (68.1%)

 Weight (kg)

75.0 ± 14.0

75.6 ± 15.0

 Height (cm)

177 ± 9

174 ± 23

 BSA (m2)

1.92 ± 0.19

1.92 ± 0.22

 BMI (kg·m−2)

23.9 ± 4.1

24.1 ± 3.8

Indication LVAD implantation

 Hypertrophic CMP

3 (2.5%)

1 (1.4%)

 Ischemic CMP

25 (21.2%)

16 (22.2%)

 Non-compaction CMP

5 (4.2%)

0 (0.0%)

 Dilating CMP

85 (72.0%)

52 (72.2%)

 Myocarditis

0 (0.0%)

1 (1.4%)

 Congenital CMP

0 (0.0%)

1 (1.4%)

 Toxic CMP

0 (0.0%)

1 (1.4%)

Medical History

 Diabetes Mellitus

9 (7.6%)

10 (13.9%)

 Hypertension

10 (8.5%)

10 (13.9%)

 Hypercholesterolemia

12 (10.2%)

11 (15.3%)

 Smoking history

64 (54.2%)

25 (34.7%)

 Thyroid disease

15 (12.7%)

7 (9.7%)

 COPD

13 (11.0%)

9 (12.5%)

 Stroke

7 (5.9%)

4 (5.6%)

 Transient Ischemic Attack

6 (5.1%)

3 (4.2%)

 Previous Cardiothoracic surgery

14 (11.9%)

13 (18.1%)

 HMIIRS

2.4 ± 1.3

1.5 ± 1.0

 Euroscore II

22.1 [17.3–34.0]

19.0 [12.3–34.7]

Intermacs Class

 Intermacs class I

15 (12.7%)

1 (1.4%)

 Intermacs class II

63 (53.4%)

31 (43.1%)

 Intermacs class III

33 (28.0%)

27 (37.5%)

 Intermacs class IV

7 (5.9%)

12 (16.7%)

 Intermacs class V

0 (0.0%)

0 (0.0%)

 Intermacs class VI

0 (0.0%)

1 (1.4%)